Compass Therapeutics shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Compass Therapeutics (CMPX) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Compass Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Compass Therapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Compass Therapeutics by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $204k | 58k | 3.50 |
| 2025-06-30 | $153k | 59k | 2.60 |
| 2025-03-31 | $71k | 37k | 1.90 |
| 2024-12-31 | $92k | 63k | 1.45 |
| 2024-09-30 | $39k | 21k | 1.84 |
| 2024-06-30 | $24k | 24k | 1.00 |
| 2023-12-31 | $78k | 50k | 1.56 |
| 2023-09-30 | $98k | 50k | 1.97 |
| 2023-06-30 | $159k | 50k | 3.18 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors